Johnson & Johnson said Monday that its experimental vaccine could be available for emergency use authorization by early 2021.
Johnson & Johnson said Monday that its experimental vaccine could be available for emergency use authorization by early 2021.
Johnson & Johnson’s stock jumped 8 percent Monday when news broke that the company will begin human clinical testing for a..
A source within the government says human testing has now begun on the first phase of a coronavirus vaccine. Veuer’s Tony Spitz..